Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma
出版年份 2014 全文链接
标题
Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 12, Pages e83128
出版商
Public Library of Science (PLoS)
发表日期
2014-01-01
DOI
10.1371/journal.pone.0083128
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
- (2013) Jonathan T. Sims et al. PLoS One
- Treatment with the PARP-inhibitor PJ34 causes enhanced doxorubicin-mediated cell death in HeLa cells
- (2012) Natisha Magan et al. ANTI-CANCER DRUGS
- Chloroquine overcomes resistance of lung carcinoma cells to the dual PI3K/mTOR inhibitor PI103 by lysosome-mediated apoptosis
- (2012) Stefanie Enzenmüller et al. ANTI-CANCER DRUGS
- GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell death
- (2012) Stefanie Enzenmüller et al. CANCER LETTERS
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process
- (2012) P Gonzalez et al. CELL DEATH AND DIFFERENTIATION
- Paracrine Signaling Through MYCN Enhances Tumor-Vascular Interactions in Neuroblastoma
- (2012) Y. H. Chanthery et al. Science Translational Medicine
- Neuroblastoma
- (2012) Andrew M. Davidoff Seminars in Pediatric Surgery
- Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1
- (2011) Rong Zeng et al. ACTA PHARMACOLOGICA SINICA
- Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: Efficacy and underlying mechanisms
- (2011) Sabine Mueller et al. CANCER LETTERS
- Modulation of the Tumor Microvasculature by Phosphoinositide-3 Kinase Inhibition Increases Doxorubicin Delivery In Vivo
- (2011) N. Qayum et al. CLINICAL CANCER RESEARCH
- Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
- (2011) G. Prasad et al. NEURO-ONCOLOGY
- Doxorubicin-induced cell death requires cathepsin B in HeLa cells
- (2010) S. Bien et al. BIOCHEMICAL PHARMACOLOGY
- Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy
- (2010) Christina M. Coughlin et al. BREAST CANCER RESEARCH AND TREATMENT
- Combination Therapy Targeting Both Tumor-Initiating and Differentiated Cell Populations in Prostate Carcinoma
- (2010) A. Dubrovska et al. CLINICAL CANCER RESEARCH
- Neuroblastoma: Biology, Prognosis, and Treatment
- (2010) Julie R. Park et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- VDAC, a multi-functional mitochondrial protein regulating cell life and death
- (2010) Varda Shoshan-Barmatz et al. MOLECULAR ASPECTS OF MEDICINE
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
- (2010) Massimo Ammirante et al. NATURE
- PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis
- (2010) A Bender et al. ONCOGENE
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
- (2010) H. Caren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non-Small Cell Lung Cancer Harboring K-RAS Mutations
- (2009) G. Konstantinidou et al. CANCER RESEARCH
- Inhibiting PI3K as a therapeutic strategy against cancer
- (2009) Luis Paz-Ares et al. Clinical & Translational Oncology
- Rapamycin protects against rotenone-induced apoptosis through autophagy induction
- (2009) T. Pan et al. NEUROSCIENCE
- The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair
- (2009) M -A Westhoff et al. ONCOGENE
- High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene
- (2008) Helena Caren et al. BMC GENOMICS
- Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor- and Drug-Induced Apoptosis
- (2008) D. Opel et al. CANCER RESEARCH
- Targeting the Phosphoinositide 3-Kinase Isoform p110 Impairs Growth and Survival in Neuroblastoma Cells
- (2008) D. Boller et al. CLINICAL CANCER RESEARCH
- The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma
- (2008) Philipp Baumann et al. EXPERIMENTAL CELL RESEARCH
- Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents
- (2008) Michael Degtyarev et al. JOURNAL OF CELL BIOLOGY
- Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells
- (2008) R. C-Y. Hui et al. MOLECULAR CANCER THERAPEUTICS
- PI3K/Akt: getting it right matters
- (2008) T F Franke ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now